Introduction
Heart disease is the most common cause of death in postmenopausal women [1] . One in 2.4 women will die of coronary disease or stroke according to the most recent American Heart Association (AHA) data [2] . Despite the fact that cardiovascular disease (CVD) kills more women than the next 14 causes of death combined, women are still unaware of their risks. A survey from the AHA reported that although women felt they were well informed in the area of CVD, fewer than 10% considered CVD to be the greatest risk to their health. Of the 1000 women interviewed, 62% responded that cancer was the most likely disease to affect their health, and this was unchanged from the 61% response in 1997 [3] . Younger women, ages 25 to 34, have an even greater misperception of the lifelong risks from cancer, with 72% reporting cancer as their greatest health risk in 2000. In reality, women are at nearly twice the risk of dying from CVD than all types of cancer, and their lifetime risk of death from CVD is 10-fold greater than from breast cancer. Health care providers may contribute to this misperception by not providing information. In 2000, only 38% of physicians discussed heart disease with women patients who are most likely to receive health information from magazines [3] . Awareness and intervention gaps require ongoing education of both patient and provider. The tools and evidence are available to prevent many more coronary heart disease (CHD) and stroke events. Implementation of effective risk reduction programs can and should be improved through ongoing efforts [4] .
Opinion statement
Appropriate screening and lifestyle modification are the foundations of effective cardiovascular disease (CVD) prevention in women. All adult women should undergo a cardiovascular risk assessment, including family history, smoking, diet, and exercise assessments, and measurement of fasting lipid profile, waist and hip dimensions, and blood pressure. Women should be advised of their 10-year estimated risk of developing a cardiovascular event using the Framingham risk calculator as recommended by the National Cholesterol Education Program. Based on the level of risk, women should receive counseling on dietary modification, physical activity, weight loss, and the need for pharmacologic intervention for blood pressure, lipid, and diabetes management. In addition, women who are overweight, have a history of gestational diabetes, or family history of diabetes should have a fasting glucose measured. Women who smoke should receive advice, encouragement, and assistance for smoking cessation. Postmenopausal hormone therapy should not be considered a treatment option for primary or secondary prevention of CVD. Women and their families should be advised of the possible signs of CVD and the need to seek immediate medical attention in the event of prolonged, new, or severe symptoms. Women with coronary artery disease especially need close attention to their risk factor levels and should receive intensive intervention to achieve optimal control.
Prevention
The risk factors for CVD are similar for women and men, but women develop clinical CVD approximately a decade later in life than men. Despite the delay in clinical events, women have an increased incidence of hypertension, diabetes, and dyslipidemia after natural or surgical menopause, and women have higher rates of hypertension and diabetes at the time of clinical presentation with CVD. The potential for delay or reversal of cardiac events using hormone therapy has been a ripe subject for investigation. Yet, the clinical trials to date have not yielded expected results. The major focus for additional delay and prevention of CVD for women must be on risk factor identification and modification.
Individual CVD risk assessment is being widely advocated as the initial component of a CVD prevention program for every adult, including women [5••,6•]. Assessment of absolute cardiac risk by the application of the Framingham global risk score provides an estimate of the 10-year risk for cardiovascular events based on age and standard risk factors [7, 8] . The online and downloadable versions of the risk calculator tool permit ready application in the clinical office setting and serve to educate patients as well as to guide specific risk factor interventions ( Fig. 1) [9] .
Lifestyle choices of diet, exercise habits, and smoking cessation are the first steps toward global CVD risk reduction. Smoking doubles the risk of developing CVD and, when coupled with obesity, produces even deadlier outcomes. High-fat and high-calorie diets have contributed to obesity, insulin resistance, and diabetes, with resultant increases in CVD. Successfully intervening in long-standing behaviors remains the most difficult management issue in primary prevention. Despite good intentions to treat modifiable risk factors with medications, the medical community has not become skilled in the techniques best suited to change patients' lifestyles. Combating CVD with medications alone will not be successful if we cannot successfully encourage patients to discontinue smoking, partake in healthy diet, and engage in aerobic exercise.
Treatment
• Appropriate for everyone, but especially those at risk for or with known CVD.
Diet
• Obesity is directly related to increased risk of CHD, as demonstrated by multiple prospective cohort studies, and is considered a major risk factor by the AHA [10].
• Women should limit their fat intake (or calories from fat) to 25% to 35% of total daily intake (with saturated fat intake limited to less than 7%), and their cholesterol intake to less than 200 mg/d. • Current AHA guidelines encourage a Mediterranean style, reduced-fat diet consisting of fish, vegetables, and fruits, with limitations on sodium and alcohol intake [11] . Long-chain omega-3 fatty acids found in fish improve endothelial dysfunction, reduce platelet aggregation, and decrease triglycerides. Recently, investigators from the Nurses' Health Study showed that consumption of fish twice weekly is associated with lower CHD risk and death from CHD [12] . . Each item is entered and the global score calculated. The resulting score estimates the 10-year risk for "hard" coronary heart disease outcomes (eg, myocardial infarction, coronary artery death). This tool is designed to estimate risk in adults aged 20 and older who do not have heart disease or diabetes. The 10-year risk for diabetic patients can be estimated by using the full-risk tables available in other publications [7, 8] . HDL-high-density lipoprotein.
(From the National Cholesterol Education Program [9] .)
